Oral administration of hyaluronan reduces bone turnover in ovariectomized rats – Forum

Date: 2013-02-09

Reference number: OPUSeJ 201302091731OHO

Links: to published article: http://www.ncbi.nlm.nih.gov/pubmed/23256527

to pre-reviewed version: http://www.opusej.org/wp-content/uploads/2013/03/OPUSeJ-201302091731OHOpdf.pdf

to cover page: http://www.opusej.org/library/oral-administration-of-hyaluronan-reduces-bone-turnover-in-ovariectomized-rats-cover/

Title: Oral administration of hyaluronan reduces bone turnover in ovariectomized rats

Authors:  Ma, Jenny, Patrick V. Granton, David W. Holdsworth, and Eva A. Turley

Moderator: N/A

Overview: N/A

Addendum: none

Erratum: none

Bibliography: (alphabetical) N/A


(1) Choong, K.; Basaria, S. Emerging cardiometabolic complications of androgen deprivation therapy. Aging Male 2010, 13 (1), 1−9. http://informahealthcare.com/doi/abs/10.3109/13685530903410625

(2) Li, W. F.; Hou, S. X.; Yu, B.; Li, M. M.; Ferec, C.; Chen, J. M. Genetics of osteoporosis: accelerating pace in gene identification and validation. Hum. Genet. 2010, 127 (3), 249−285. http://www.ncbi.nlm.nih.gov/pubmed/20101412

(3) Mangione, R. A. Celiac disease and osteoporosis. Am. J. Health Syst. Pharm. 2008, 65 (17), 1601; author reply 1601−1602.

(4) Post, T. M.; Cremers, S. C.; Kerbusch, T.; Danhof, M. Bone physiology, disease and treatment: towards disease system analysis in osteoporosis. Clin. Pharmacokinet. 2010, 49 (2), 89−118. http://www.ncbi.nlm.nih.gov/pubmed/20067335

(5) Sabo, D.; Bernd, L.; Pfeil, J.; Reiter, A. Bone quality in the lumbar spine in high-performance athletes. Eur. Spine J. 1996, 5 (4), 258−263. http://www.ncbi.nlm.nih.gov/pubmed/8886738

(6) Tucker, K. L. Osteoporosis prevention and nutrition. Curr. Osteoporosis Rep. 2009, 7 (4), 111−117. http://www.ncbi.nlm.nih.gov/pubmed/19968914

(7) Cao, J. J.; Singleton, P. A.; Majumdar, S.; Boudignon, B.; Burghardt, A.; Kurimoto, P.; Wronski, T. J.; Bourguignon, L. Y.; Halloran, B. P. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. J. Bone Miner. Res. 2005, 20 (1), 30−40. http://www.ncbi.nlm.nih.gov/pubmed/15619667

(8) Prince, C. W. Roles of hyaluronan in bone resorption. BMC 442 Musculoskeletal Disord. 2004, 5, 12−15. 443 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC411043/

(9) Bastow, E. R.; Byers, S.; Golub, S. B.; Clarkin, C. E.; Pitsillides, A. A.; Fosang, A. J. Hyaluronan synthesis and degradation in cartilage and bone. Cell. Mol. Life Sci. 2008, 65 (3), 395−413. 446 http://www.ncbi.nlm.nih.gov/pubmed/17965830

(10) Pilloni, A.; Bernard, G. W. The effect of hyaluronan on mouse intramembranous osteogenesis in vitro. Cell Tissue Res. 1998, 294 (2), 323−333. http://link.springer.com/article/10.1007%2Fs004410051182?LI=true

(11) Aslan, M.; Simsek, G.; Dayi, E. The effect of hyaluronic acid-supplemented bone graft in bone healing: experimental study in rabbits. J. Biomater. Appl. 2006, 20 (3), 209−220. http://www.ncbi.nlm.nih.gov/pubmed/16364962

(12) Chazono, M.; Tanaka, T.; Komaki, H.; Fujii, K. Bone formation and bioresorption after implantation of injectable β-tricalcium phosphate granules-hyaluronate complex in rabbit bone defects. J. Biomed. Mater. Res. A 2004, 70 (4), 542−549. http://www.ncbi.nlm.nih.gov/pubmed/15307158

(13) Moffatt, P.; Lee, E. R.; St-Jacques, B.; Matsumoto, K.; Yamaguchi, Y.; Roughley, P. J. Hyaluronan production by means of Has2 gene expression in chondrocytes is essential for long bone development. Dev. Dyn. 2011, 240 (2), 404−412. 460 http://www.ncbi.nlm.nih.gov/pubmed/21246657

(14) Asari, A.; Kanemitsu, T.; Kurihara, H. Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium. J. Biol. Chem. 2010, 285 (32), 24751−24758. 464 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915711/

(15) Balogh, L.; Polyak, A.; Mathe, D.; Kiraly, R.; Thuroczy, J.; Terez, M.; Janoki, G.; Ting, Y.; Bucci, L. R.; Schauss, A. G. Absorption, uptake and tissue affinity of high-molecular-weight hyaluronan after oral administration in rats and dogs. J. Agric. Food Chem. 2008, 56 (22), 10582−10593. http://www.ncbi.nlm.nih.gov/pubmed/18959406

(16) Stancikova, M.; Svik, K.; Istok, R.; Rovensky, J.; Velebny, V. The effects of hyaluronan on bone resorption and bone mineral density in a rat model of estrogen deficiency-induced osteopenia. Int. J. Tissue React. 2004, 26 (1−2), 9−16. 473 http://www.ncbi.nlm.nih.gov/pubmed/15573687

(17)Jiang, D.; Liang, J.; Noble, P. W. Hyaluronan in tissue injury and repair. Annu. Rev. Cell Dev. Biol. 2007, 23, 435−461. 475 Hyaluronan in tissue injury and repair. http://www.ncbi.nlm.nih.gov/pubmed/15573687

(18) Kim, Y. S.; Koh, J. M.; Lee, Y. S.; Kim, B. J.; Lee, S. H.; Lee, K. U.; Kim, G. S. Increased circulating heat shock protein 60 induced by menopause, stimulates apoptosis of osteoblast-lineage cells via up-regulation of toll-like receptors. Bone 2009, 45 (1), 68−76. http://www.sciencedirect.com/science/article/pii/S875632820901206X

(19) Granton, P. V.; Norley, C. J.; Umoh, J.; Turley, E. A.; Frier, B.C.; Noble, E. G.; Holdsworth, D. W. Rapid in vivo whole body composition of rats using cone beam muCT. J. Appl. Physiol. 2010, 109 (4), 1162−1169. 483 http://ir.lib.uwo.ca/robartspub/9/

(20) Lewiecki, E. M. Benefits and limitations of bone mineral density and bone turnover markers to monitor patients treated for osteoporosis. Curr. Osteoporosis Rep. 2010, 8 (1), 15−22. 486 http://www.ncbi.nlm.nih.gov/pubmed/20425086

(21) Haserodt, S.; Aytekin, M.; Dweik, R. A. A comparison of the sensitivity, specificity, and molecular weight accuracy of three different commercially available hyaluronan ELISA-like assays. Glycobiology 2011, 21 (2), 175−183. 490 http://www.ncbi.nlm.nih.gov/pubmed/20864567

(22) Simarro, M.; Mauger, D.; Rhee, K.; Pujana, M. A.; Kedersha, N. L.; Yamasaki, S.; Cusick, M. E.; Vidal, M.; Garcia-Blanco, M. A.; Anderson, P. Fas-activated serine/threonine phosphoprotein (FAST) is a regulator of alternative splicing. Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (27), 11370−11375. 495 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040905/

(23) Cox, G.; Einhorn, T. A.; Tzioupis, C.; Giannoudis, P. V. Bone-turnover markers in fracture healing. J. Bone Jt. Surg., Br. Vol. 2010, 92 (3), 329−334. 498 http://www.ncbi.nlm.nih.gov/pubmed/20190300

(24) Sendur, O. F.; Turan, Y.; Tastaban, E.; Serter, M. Antioxidant status in patients with osteoporosis: a controlled study. Joint, Bone, Spine 2009, 76 (5), 514−518. http://www.ncbi.nlm.nih.gov/pubmed/19464221

(25) Compston, J. Monitoring bone mineral density during antiresorptive treatment for osteoporosis. BMJ 2009, 338, b1276. http://www.bmj.com/content/338/bmj.b1276

(26) Muller, R. Hierarchical microimaging of bone structure and function. Nat. Rev. Rheumatol. 2009, 5 (7), 373−381. http://www.ncbi.nlm.nih.gov/pubmed/19568252

(27) Kalu, D. N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 1991, 15 (3), 175−191. Journal of Agricultural and Food Chemistry Article F dx.doi.org/10.1021/jf300651d |J. Agric. Food Chem. http://www.ncbi.nlm.nih.gov/pubmed/1773131

(28) Lelovas, P. P.; Xanthos, T. T.; Thoma, S. E.; Lyritis, G. P.; Dontas, I. A. The laboratory rat as an animal model for osteoporosis research. Comp. Med. 2008, 58 (5), 424−430. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707131/

(29) Huang, L.; Cheng, Y. Y.; Koo, P. L.; Lee, K. M.; Qin, L.; Cheng, J. C.; Kumta, S. M. The effect of hyaluronan on osteoblast proliferation and differentiation in rat calvarial-derived cell cultures. J. Biomed. Mater. Res. A 2003, 66 (4), 880−884. http://www.ncbi.nlm.nih.gov/pubmed/12926041

(30) Banzato, A.; Rondina, M.; Melendez-Alafort, L.; Zangoni, E.; Nadali, A.; Renier, D.; Moschini, G.; Mazzi, U.; Zanovello, P.; Rosato, A. Biodistribution imaging of a paclitaxel-hyaluronan bioconjugate. Nucl. Med. Biol. 2009, 36 (5), 525−533. http://www.ncbi.nlm.nih.gov/pubmed/19520293

(31) Jiang, D.; Liang, J.; Noble, P. W. Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 2011, 91 (1), 221−264. http://physrev.physiology.org/content/91/1/221.abstract

(32) Shirali, A. C.; Goldstein, D. R. Activation of the innate immune system by the endogenous ligand hyaluronan. Curr. Opin. Organ Transplant. 2008, 13 (1), 20−25. http://www.ncbi.nlm.nih.gov/pubmed/18660702

(33) Rahman, M. M.; Bhattacharya, A.; Banu, J.; Kang, J. X.; Fernandes, G. Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis. J. Cell. Mol. Med. 2009, 13 (8B), 1833−1844. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855756/

(34) Villegas-Navarro, A.; Dominguez, R.; Reyes, J. L.; Dieck, T. A. In vitro lead cation-hyaluronic acid interaction. Exp. Toxicol. Pathol. 1995, 47 (5), 409−411. http://www.ncbi.nlm.nih.gov/pubmed/8871075

(35) Blokhuis, T. J. Formulations and delivery vehicles for bone morphogenetic proteins: latest advances and future directions. Injury 2009, 40 (Suppl. 3), S8−11. http://www.sciencedirect.com/science/article/pii/S002013830970004X

(36) Lewis, K. N.; Thomas, M. V.; Puleo, D. A. Mechanical and degradation behavior of polymer-calcium sulfate composites. J. Mater. Sci. Mater. Med. 2006, 17 (6), 531−537. http://www.ncbi.nlm.nih.gov/pubmed/16691351

(37) Dawes, J.; Hodson, B. A.; Pepper, D. S. The absorption, clearance and metabolic fate of dermatan sulphate administered to man − studies using a radioiodinated derivative. Thromb. Haemost.1989, 62 (3), 945−949. http://www.ncbi.nlm.nih.gov/pubmed/2595665

(38) Reed, R. K.; Townsley, M. I.; Pitts, V. H.; Laurent, T. C.; Taylor, A. E. Increased lymphatic flux of hyaluronan from cat intestine during fat absorption. Am. J. Physiol. 1992, 263 (1 Part 1), G6−11. Journal of Agricultural and Food Chemistry A http://www.ncbi.nlm.nih.gov/pubmed/1636716

Citation: Ma J, et al, 2013, “Oral administration of hyaluronan reduces bone turnover in ovariectomized rats”, J Agric Food Chem. 16:61(2). 339-45. doi: 10.1021/jf300651d. Epub 2013 Jan 8. http://www.ncbi.nlm.nih.gov/pubmed/23256527

Academic citations forward: none

Other citations forward: none

Leave a Reply